BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 6332827)

  • 1. Decreased methionine synthesis in purine nucleoside-treated T and B lymphoblasts and reversal by homocysteine.
    Boss GR; Pilz RB
    J Clin Invest; 1984 Oct; 74(4):1262-8. PubMed ID: 6332827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purine deoxynucleosides and adenosine dialdehyde decrease 5-amino-4-imidazolecarboxamide (Z-base)-dependent purine nucleotide synthesis in cultured T and B lymphoblasts.
    Boss GR
    Biochem J; 1987 Mar; 242(2):425-31. PubMed ID: 3109390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased methionine synthesis in purine nucleoside treated T and B lymphoblasts: reversal by homocysteine.
    Boss GR
    Adv Exp Med Biol; 1986; 195 Pt A():521-3. PubMed ID: 3487923
    [No Abstract]   [Full Text] [Related]  

  • 4. S-adenosylhomocysteine hydrolase inactivation and purine toxicity in cultured human T- and B-lymphoblasts.
    Young GJ; Hallam LJ; Jack I; Van Der Weyden MB
    J Lab Clin Med; 1984 Jul; 104(1):86-95. PubMed ID: 6330251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-Adenosylhomocysteine accumulation and selective cytotoxicity in cultured T- and B-lymphocytes.
    Palella TD; Schatz RA; Wilens TE; Fox IH
    J Lab Clin Med; 1982 Aug; 100(2):269-78. PubMed ID: 6980250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of purine nucleoside phosphorylase: effects of 9-deazapurine ribonucleosides and synthesis of 5'-deoxy-5'-iodo-9-deazainosine.
    Stoeckler JD; Ryden JB; Parks RE; Chu MY; Lim MI; Ren WY; Klein RS
    Cancer Res; 1986 Apr; 46(4 Pt 1):1774-8. PubMed ID: 3081256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
    Wilson JM; Mitchell BS; Daddona PE; Kelley WN
    J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of purine nucleosides and enzyme inhibitors for selective depletion of Thy-lymphoblasts from human bone marrow.
    Russell NH; Hoffbrand AV; Bellingham AJ
    Leuk Res; 1986; 10(3):325-9. PubMed ID: 3081767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
    Dong MK; Scott ME; Schrier DJ; Suto MJ; Sircar JC; Black A; Chang T; Gilbertsen RB
    J Pharmacol Exp Ther; 1992 Jan; 260(1):319-26. PubMed ID: 1530976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2'-deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation.
    Sidi Y; Mitchell BS
    J Clin Invest; 1984 Nov; 74(5):1640-8. PubMed ID: 6334099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of the salvage of purine compounds on the proliferation of rat T-lymphocytes with normal or inhibited purine de novo synthesis.
    Thuillier L; Perignon JL; Houllier AM; Munier A; Cartier P
    Biochim Biophys Acta; 1984 Apr; 798(3):343-9. PubMed ID: 6424727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of guanine ribonucleotide accumulation on the metabolism and cell cycle of human lymphoid cells.
    Sidi Y; Hudson JL; Mitchell BS
    Cancer Res; 1985 Oct; 45(10):4940-5. PubMed ID: 2411392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T lymphoblasts.
    Kazmers IS; Mitchell BS; Dadonna PE; Wotring LL; Townsend LB; Kelley WN
    Science; 1981 Dec; 214(4525):1137-9. PubMed ID: 6795718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolism of deoxyguanosine and guanosine in human B and T lymphoblasts. A role for deoxyguanosine kinase activity in the selective T-cell defect associated with purine nucleoside phosphorylase deficiency.
    Osborne WR; Scott CR
    Biochem J; 1983 Sep; 214(3):711-8. PubMed ID: 6312962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cells as well as T cells form deoxynucleotides from either deoxyadenosine or deoxyguanosine.
    Goday A; Simmonds HA; Morris GS; Fairbanks LD
    Clin Exp Immunol; 1984 Apr; 56(1):39-48. PubMed ID: 6424986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential metabolism of guanine nucleosides by human lymphoid cell lines.
    Mitchell BS; Sidi Y
    Proc Soc Exp Biol Med; 1985 Sep; 179(4):427-31. PubMed ID: 3875100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).
    Carson DA; Kaye J; Seegmiller JE
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5677-81. PubMed ID: 202960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of methylmercaptopurine ribonucleoside cytotoxicity by purine ribonucleosides and adenine.
    Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Vogels-Mentink TM; Keizer-Garritsen JJ; Trijbels FJ
    Biochem Pharmacol; 1995 Jan; 49(1):49-56. PubMed ID: 7840782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of apoptosis induced by purine nucleosides in astrocytes.
    Di Iorio P; Kleywegt S; Ciccarelli R; Traversa U; Andrew CM; Crocker CE; Werstiuk ES; Rathbone MP
    Glia; 2002 May; 38(3):179-90. PubMed ID: 11968056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.